1. Home
  2. ICCM vs AIDX Comparison

ICCM vs AIDX Comparison

Compare ICCM & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.72

Market Cap

3.6M

Sector

N/A

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.21

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ICCM
AIDX
Founded
2006
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
2.9M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
ICCM
AIDX
Price
$0.72
$0.21
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $22.67
N/A
AVG Volume (30 Days)
110.0K
★ 235.3K
Earning Date
11-18-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.48
EPS
★ N/A
N/A
Revenue
N/A
★ $2,045,133.00
Revenue This Year
$27.11
$44.20
Revenue Next Year
$104.97
$95.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.13
$0.18
52 Week High
$9.54
$18.96

Technical Indicators

Market Signals
Indicator
ICCM
AIDX
Relative Strength Index (RSI) 29.69 33.68
Support Level $0.65 $0.18
Resistance Level $0.74 $0.27
Average True Range (ATR) 0.10 0.03
MACD 0.02 0.01
Stochastic Oscillator 18.43 23.17

Price Performance

Historical Comparison
ICCM
AIDX

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: